Clearly, further glycomic studies on more CRC cell lines as well as CDX1-knockdown cell lines and cells with forced CDX1 expression are needed to evaluate whether CDX1 acts as an inducer of the associated glycomic profiles, and assays on aggressiveness/invasiveness of corresponding cell lines are required to show the biological relevance. Here, CDX1 is linked to colorectal carcinoma.